The MAHA Institute, a think tank formed by allies of Robert F. Kennedy Jr. after his appointment as health secretary, convened an event in Washington on Monday that made the case for dramatically loosening restrictions on health data sharing in the United States.

The centerpiece of the event was a specific proposal: sharing patients' health records directly with federal researchers. Speakers argued that broadening researchers' access to this data could benefit the study of the origins of chronic diseases, a research priority aligned with the broader Make America Healthy Again agenda that Kennedy has championed since taking over the Department of Health and Human Services.

For research managers and principal investigators, the push raises concrete questions about data infrastructure, consent frameworks and study design. Large-scale access to longitudinal patient records has historically been constrained by privacy regulations — chiefly HIPAA — and by the fragmented nature of electronic health record systems across US providers. Any policy shift that opens federal researcher access to those records would alter the calculus for epidemiological studies of chronic disease, potentially enabling larger cohorts and longer follow-up periods than institution-by-institution data sharing agreements currently allow.

The event's framing treats patient records as an underused national research asset. That claim warrants scrutiny. The MAHA Institute is a partisan-aligned think tank rather than an independent research body, and its event served in part to advance the policy agenda of Kennedy's Health and Human Services Department. The organization did not present, at least in the portion of the event described publicly, peer-reviewed evidence quantifying how much faster chronic disease research would proceed under expanded data access, nor details on consent models, de-identification standards or governance mechanisms that would determine whether such a program is workable in practice.

The proposal also lands in an ongoing policy fight. Health data interoperability and patient access have been the subject of federal rulemaking for years, and previous administrations have pushed — with mixed results — to make records more portable for patients and usable by researchers. What distinguishes the MAHA Institute's positioning is the destination of the data: federal researchers specifically, rather than patients themselves or the broader research community. That distinction matters for institutions weighing data-sharing partnerships with the government, since it concentrates access within federal agencies whose research priorities are now set by Kennedy's department.

Chronic disease origins have become a signature focus of the MAHA movement, and expanded record access is positioned as the evidentiary backbone for that agenda. Whether federal researchers can translate bulk patient records into reliable findings on chronic disease causation will depend on variables the event did not fully address: data quality across heterogeneous electronic health record systems, the representativeness of the patient populations whose records would be shared, and the statistical limits of observational data when studying multifactorial conditions.

The Monday event signals that the push for accessible health data is moving from rhetorical priority to organized policy advocacy. Researchers and research administrators should expect the debate over who gets access to patient records — and under whose authority — to intensify as the MAHA Institute and the health secretary's allies press their case.